Intellia Appoints Caroline Dorsa To Company’s Board Of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Intellia Therapeutics, Inc., a leading gene-editing company, has named Caroline Dorsa to its Board of Directors. Both as a director and business leader, Ms. Dorsa brings over 30 years of diverse experience and management in the public sector and regulated industries, including energy, pharmaceuticals and telecommunications.

Back to news